For much of cryptocurrencies existence, short-term trading strategies that seek to benefit from high volatility and sudden momentum shifts defined the cryptocurrency market. But with the recent arrival of institutional investors, as well as new thinking about how crypto could represent an entirely new asset class, that appears to be changing. More thinking is going into how to make crypto…
Is the calmness of the last few months going to continue for much longer? Or is there some wild volatility on the horizon? Key questions and topics David asked me include: After the recent pullback, is momentum going to the upside or downside? What are the early warning indicators that the market may be changing direction? Looking at the VIX,…
Cheap OTC penny stocks (those that trade on the Over-the-Counter exchange) have the potential to provide game-changing returns, or break your portfolio. These are some of the most high-risk, high-reward investments you can make. The potential for colossal gains is undoubtedly alluring, but it’s a double-edged sword. These stocks typically trade with very low volume, and rapid moves are possible…
The Dow Jones Industrial Average made history this past Thursday, reaching the 40,000-point mark for the first time ever. It broke over 40,000 at about 10:30 a.m. Eastern but closed on Thursday just below that mark at 39,869. On Friday, the Dow managed to close just above 40,000, and it remained above that key level in early trading on Monday.…
Gold has experienced a considerable surge in its value recently. The yellow metal rose past $2,400 per ounce, setting a new record, driven by safe-haven demand, central bank purchases, growing anticipation of interest rate cuts by the Fed, and ongoing geopolitical tensions. Given the industry’s shiny prospects, investors could consider buying these three fundamentally sound gold stocks for exciting returns in…
Biotechnology is an interesting place to look if you’re looking for growth and are not put off by severe levels of volatility. Undoubtedly, there’s a bit of speculative zest regarding some of the smaller biotech stocks out there, many of whom depend on just a handful of pipeline candidates. While the level of growth is more sizeable with small- and mid-cap biotech…
“Sell in May and go away.” Craig Hemke from Sprott Money and I discuss whether there is any truth to this common seasonality saying or whether the indexes and precious metals will continue to hit new highs, keeping traders glued to their seats. Our discussion covered the following topics and questions: Starting with the US equity markets, how is it…
Investing doesn’t need to be hard. Just a couple of well-chosen exchange-traded funds (ETFs) can make it easy — and lucrative. Read on to learn about two great ETFs that can help you safely profit from the growth of the global economy and instantly diversify your portfolio with exposure to thousands of stocks. This post originally appeared at The Motley…
Is climate change real? I do not know, but not because I have ignored it or refused to examine the evidence. In fact, I have meticulously absorbed tons of evidence, engaged in conversations with actual scientists on both sides of the debate, endured demagoguery from advocates of both sides of the question, and painstakingly sorted through piles of data until…
American retirees are gingerly making their way through their golden years, treading forward as all sorts of economic minefields surround them. Maybe that’s why 63% of Americans are more worried about running out of cash in retirement than dying, according to a new Allianz Life study. That’s where being disciplined and creative about low-risk but potentially high-return investments can help, even…